Molhoek, K. R., Brautigan, D. L., & Slingluff, C. L. (2005). Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin. BioMed Central.
Chicago Style CitationMolhoek, Kerrington R., David L. Brautigan, i Craig L. Slingluff. Synergistic Inhibition of Human Melanoma Proliferation By Combination Treatment With B-Raf Inhibitor BAY43-9006 and MTOR Inhibitor Rapamycin. BioMed Central, 2005.
Cita MLAMolhoek, Kerrington R., David L. Brautigan, i Craig L. Slingluff. Synergistic Inhibition of Human Melanoma Proliferation By Combination Treatment With B-Raf Inhibitor BAY43-9006 and MTOR Inhibitor Rapamycin. BioMed Central, 2005.
Atenció: Aquestes cites poden no estar 100% correctes.